This Phase 1 trial, evaluating VK2735 (dosed subcutaneously) for metabolic disorders, demonstrated an encouraging safety and tolerability profile as well as positive signs of clinical benefit
Both medications share a similar side effect profile primarily nausea, stomach upset, constipation, and occasional vomiting, especially during the early weeks when the dose is being increased
Can semaglutide dosage be adjusted based on results
@ehplabs sipping on #Oxyshred code:BREFIT @SS Sculpt on the body Workout diary day 1
Safety, Side Effects, and Menopause-Specific Considerations Semaglutide is generally well-tolerated, with the most common side effects being mild nausea, constipation, and reduced appetiteironically, the reduced appetite is the desired effect